Cyclosporine induced bradycardia: is it rarely seen?
Journal of Cardiology & Cardiovascular Surgery · 2023
DOI: 10.51271/jccvs-0005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiology & Cardiovascular Surgery, 2023. Verfasst von Deniz Mutlu und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Immunosuppressive patients experience various side effects from their treatment. Cyclosporine is a commonly prescribed immunomodulatory agent with an increasing clinical applications. Although most common documented side effect is nephropathy, it can cause some cardiac side effects. This report presents a rare side effect of cyclosporine; bradycardia attacks in an immunosuppressed patient.
Zitieren
APA
Mutlu, D., Kültürsay, B., Akman, Z., Ünal, M., Mutlu, Ö. P. Z., & Polat, F. (2023). Cyclosporine induced bradycardia: is it rarely seen?. Journal of Cardiology & Cardiovascular Surgery. https://doi.org/10.51271/jccvs-0005
Vancouver
Mutlu D, Kültürsay B, Akman Z, Ünal M, Mutlu ÖPZ, Polat F. Cyclosporine induced bradycardia: is it rarely seen?. Journal of Cardiology & Cardiovascular Surgery. 2023. doi:10.51271/jccvs-0005
BibTeX
@article{Mutlu2023,
author = {Mutlu, Deniz and Kültürsay, Barkın and Akman, Zafer and Ünal, Murat and Mutlu, Özgecan Pırıl Zanbak and Polat, Fuat},
title = {Cyclosporine induced bradycardia: is it rarely seen?},
journal = {Journal of Cardiology & Cardiovascular Surgery},
year = {2023},
doi = {10.51271/jccvs-0005}
}
EUVIMED